Trials
Search / Trial NCT06439017

Passive Thoughts in Functional Movement Disorders

Launched by WESTERN UNIVERSITY, CANADA · May 27, 2024

Trial Information

Current as of February 18, 2025

Not yet recruiting

Keywords

ClinConnect Summary

To evaluate passive thoughts in functional movement disorders (FMD), we will collect data from 30 FMD patients and 30 healthy controls. Patients will be recruited from the movement disorders clinic and the integrated functional movement disorders clinic at LHSC. Both groups will be asked to complete the paper-based Mind Excessively Wandering Scale (MEWS) to evaluate passive thoughts. Additionally, FMD patients will complete the World Health Organization Disability Assessment Schedule 2.0 (WHODAS 2.0), a 36-item self-administered questionnaire designed to measure disability over the past 30 ...

Gender

ALL

Eligibility criteria

  • Inclusion criteria for cases:
  • 1. Diagnosed with a functional movement disorder by the neurologist.
  • 2. Able to understand and read English.
  • Exclusion criteria for cases:
  • 1. Unable to understand and read English.
  • 2. Diagnosed with dementia.

About Western University, Canada

Western University, located in Canada, is a leading research institution committed to advancing healthcare through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, the university harnesses the expertise of its faculty and research teams to conduct high-quality studies that address pressing medical challenges. Western University is dedicated to fostering a culture of ethical research practices, ensuring participant safety, and generating impactful findings that contribute to evidence-based medicine and improve patient outcomes. Through its robust infrastructure and commitment to excellence, Western University plays a vital role in the field of clinical research.

Locations

London, Ontario, Canada

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0